Primary pulmonary hypertension associated with the use of fenfluramine derivatives.
暂无分享,去创建一个
M. Humbert | G. Simonneau | O. Sitbon | P. Hervé | M. Fartoukh | J. Jagot | Marc Humbert | Muriel Fartoukh | P. Hervé | JL Jagot
[1] W. Edwards,et al. Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.
[2] S. Barman. Pulmonary vasoreactivity to serotonin during hypoxia is modulated by ATP-sensitive potassium channels. , 1997, Journal of applied physiology.
[3] N. Voelkel,et al. Appetite suppressants and pulmonary hypertension , 1997, Thorax.
[4] B. Fanburg,et al. A new role for an old molecule: serotonin as a mitogen. , 1997, The American journal of physiology.
[5] N. D. Arnold,et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32 , 1997, Nature Genetics.
[6] E. Gibson,et al. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, TIPS - Trends in Pharmacological Sciences.
[7] S. Archer,et al. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. , 1996, Circulation.
[8] A. Bonev,et al. Vasoconstrictors inhibit ATP-sensitive K+ channels in arterial smooth muscle through protein kinase C , 1996, The Journal of general physiology.
[9] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[10] J. Launay,et al. Increased plasma serotonin in primary pulmonary hypertension. , 1995, The American journal of medicine.
[11] R. Naeije,et al. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. , 1995, American journal of respiratory and critical care medicine.
[12] G. Simonneau,et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. , 1994, Circulation.
[13] F. Brénot. Primary pulmonary hypertension. Case series from France. , 1994, Chest.
[14] G. Simonneau,et al. Primary pulmonary hypertension and fenfluramine use. , 1993, British heart journal.
[15] F. Artigas,et al. Simultaneous Effects of p‐Chloroamphetamine, d‐Fenfluramine, and Reserpine on Free and Stored 5‐Hydroxytryptamine in Brain and Blood , 1992, Journal of neurochemistry.
[16] D. McTavish,et al. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. , 1992, Drugs.
[17] R. Speich,et al. Primary pulmonary hypertension in HIV infection. , 1991, Chest.
[18] D. Rodman,et al. Paradoxical constriction to platelets by arteries from rats with pulmonary hypertension. , 1991, The American journal of physiology.
[19] A. Hadengue,et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. , 1991, Gastroenterology.
[20] J. Launay,et al. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. , 1990, The American journal of medicine.
[21] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[22] Gurtner Hp. [Chronic pulmonary hypertension of vascular origin, plexogenic pulmonary arteriopathy and the appetite depressant aminorex: addenda to an epidemic]. , 1985 .
[23] J. Douglas,et al. Pulmonary hypertension and fenfluramine , 1981 .
[24] F. Kaindl. [Primary pulmonary hypertension]. , 1969, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.